India Diabetes Drugs and Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

India's diabetes drugs and devices market is segmented by drugs (insulin, oral anti-diabetic drugs, non-insulin injectable drugs, and combination drugs) and devices (management devices such as insulin pumps, insulin pens, syringes, cartridges, and jet injectors, and monitoring devices including self-monitoring blood and continuous glucose monitoring). The report offers the value (in USD) and volume (in unit) for the above segments.

India Diabetes Drugs and Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

India Diabetes Drugs and Devices Industry Overview

Manufacturers have always innovated to outlive in the industry. Big firms as an example Abbott and Medtronic have made abundant mergers, acquisitions, and partnerships to attain industry dominance whereas adhering to biological development techniques. The manufacturers of insulin delivery tools are spending substantial amounts on the R&D of the tools. For example, Novo Nordisk partnered with Abbott Diabetes Care, that may additionally aid to enable insulin statistics to be shared between Novo Nordisk-connected insulin pens and digital fitness trappings well qualified to the FreeStyle Libre portfolio of cosmetics.

India Diabetes Drugs and Devices Market Leaders

  1. Medtronics

  2. Roche

  3. NovoNordisk

  4. Sanofi

  5. Omnipod

  6. *Disclaimer: Major Players sorted in no particular order
India Diabetes Drugs And Devices Market Concentration

India Diabetes Drugs and Devices Market Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?